Advanced Glycosylation End Product Specific Receptor (AGER) Antibody

REQUEST MORE INFO
Catalogue No: abx230209
Price: US$420.50
(Size: 100 µg)

Orders to United States ship from United States

Advanced Glycosylation End Product Specific Receptor (AGER) Antibody Advanced Glycosylation End Product Specific Receptor (AGER) Antibody

Click on the image to see the image legend

Available Options

* Size:

Add to Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Advanced Glycosylation End Product Specific Receptor (AGER) Antibody is a Rabbit polyclonal against Advanced Glycosylation End Product Specific Receptor (AGER).

AGER mediates interactions of advanced glycosylation end products (AGE), non-enzymatically glycosylated proteins that accumulate in vascular tissue in aging and at an accelerated rate in diabetes. AGER is a mediator of both acute and chronic vascular inflammation in conditions such as atherosclerosis and in particular as a complication of diabetes. AGE/RAGE signaling plays an important role in regulating the production/expression of TNF-alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes. It interacts with S100A12 on endothelium, mononuclear phagocytes and lymphocytes, triggers cellular activation and generates important proinflammatory mediators. It is a receptor for amyloid beta peptide and facilitates its translocation across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering ABPP asa complex with RAGE to the intraneuronal space. AGER also binds oligonucleotides.

Target Advanced Glycosylation End Product Specific Receptor (AGER)
Research Area Metabolic Pathways, Tumor Immunity, Endocrinology, Cardiovascular Biology, Neuroscience, Cancer
Clonality Polyclonal
Reactivity Human, Mouse, Rat
Tested Applications ELISA, WB, IHC
Host Rabbit
Recommended dilutions WB: 1/200 - 1/2000, IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Immunogen Advanced Glycosylation End Product Specific Receptor (AGER)
Isotype IgG
Form Liquid
Purity ≥ 95% (SDS-PAGE)
Purification Purified by immunogen affinity chromatography.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Shelf Life 12 months.
UniProt Primary AC Q15109 (UniProt, ExPASy)
UniProt Entry Name RAGE_HUMAN
KEGG hsa:177
String 9606.ENSP00000364210
Molecular Weight Observed MW: 43 kDa
Buffer PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
Concentration 2 mg/ml
Availability Shipped within 5-12 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Advanced Glycosylation End Product Specific Receptor (AGER)


Write a review

Tags:
(Click to show)